January 2025

“Experience the Future of Spinal Health: Aclarion Unveils Revolutionary NOCISCAN Technology at Selby Spine Conference”

newscaster04 mins

Dr. Sigurd Berven to Highlight NOCISCAN Capabilities, Combining MR Spectroscopy and Augmented Intelligence (AI) NOCISCAN as New Gold Standard in Identifying a Source of Discogenic Pain BROOMFIELD, Colo., Jan. 31, 2025 (GLOBE NEWSWIRE) — Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence…

Read More

“Unpacking the Latest Earnings Call: A Recap of Brookfield Renewable Corporation’s Q4 2024 Results”

ilikefinance04 mins

Brookfield Renewable Corporation (NYSE:BEPC) Q4 2024 Earnings Conference Call Highlights Key Participants: Connor Teskey – CEO Wyatt Hartley – Co-President Patrick Taylor – CFO Conference Call Participants: Sean Steuart – TD Cowen Nelson Ng – RBC Capital Markets Robert Hope – Scotiabank Rupert Merer – National Bank Mark Jarvi – CIBC William Grippin – UBS…

Read More

“Revolutionizing Transactions: Tether and Bitcoin’s Lightning Network Join Forces for Lightning-Fast Payments!”

financenews04 mins

The Game-Changing Integration of USDT Stablecoin with Bitcoin’s Lightning Network Revolutionizing the World of Cryptocurrency Transactions Recently, Tether announced a groundbreaking integration of its USDT stablecoin with Bitcoin’s Lightning Network. This integration paves the way for instant, low-cost transactions while preserving the security and decentralization of Bitcoin. By leveraging the Taproot Assets protocol, this integration…

Read More

“Coinbase Takes the Plunge: Self-Certification for Solana Futures Launch!”

marketnews05 mins

Coinbase Takes a Leap into the Future with Solana Futures Contracts Have you heard the news? Coinbase, one of the front-runners in the world of cryptocurrency exchanges, is stepping up its game with a groundbreaking move towards expanding its derivatives offerings. The company recently filed for self-certification to list Solana (SOL) futures contracts, marking a…

Read More

“Say Goodbye to Migraines: Axsome’s Symbravo Receives FDA Approval and Sends Stock Soaring!”

ilikefinance03 mins

The FDA Approves AXSM’s Symbravo for Migraine Treatment Introduction The FDA’s recent approval of AXSM’s Symbravo for the acute treatment of migraine in adults marks a significant milestone in the field of healthcare. This new medication is designed to provide relief for individuals suffering from migraines, with or without aura, offering a new option for…

Read More